Hospitalization due to pneumococcal disease in the Unified Health System in Brazil: A retrospective analysis of administrative data

Hospitalization due to pneumococcal disease in the Unified Health System in Brazil: A retrospective analysis of administrative data

Introduction: Community-Acquired Pneumonia (CAP) caused by pneumococcus and Invasive Pneumococcal Disease (IPD) pose a substantial economic burden on health systems. The objective of the present study is to explore hospitalization costs of pneumococcal disease in the public health system in Brazil,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Daniela V. Pachito, Mauricio Longato, Guilherme Cordeiro, Paulo H.R.F. Almeida, Ricardo Macarini Ferreira, Ana Paula N. Burian
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Brazilian Journal of Infectious Diseases
Subjects:	Pneumococcal infections Health care economics and organizations Costs and cost analysis Unified health system
Online Access:	http://www.sciencedirect.com/science/article/pii/S1413867024007657
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

An economic evaluation of pneumococcal conjugate vaccines, PCV20 versus PCV15, for the prevention of pneumococcal disease in the Swedish pediatric population
by: Ann-Charlotte Fridh, et al.
Published: (2024-12-01)

Response to the cost effectiveness analysis of pneumococcal conjugated vaccines in Peru
by: Jorge Alberto Gomez, et al.
Published: (2015-07-01)

Cost-effectiveness analysis of pneumococcal conjugate vaccines in preventing pneumonia in Peruvian children
by: Edward Mezones-Holguín, et al.
Published: (2014-12-01)

VACCINATION AGAINST PNEUMOCOCCAL INFECTIONS IN RUSSIAN FEDERATION: SOCIAL AND PHARMACOECONOMIC ASPECTS
by: A. V. Rudakova, et al.
Published: (2018-10-01)

Economic analysis of 15-valent and 20-valent pneumococcal conjugate vaccines among older adults in Ontario, Canada
by: Gebremedhin B. Gebretekle, et al.
Published: (2025-12-01)

PHARMACOECONOMIC EVALUATION OF INFLUENZA AND PNEUMOCOCCAL VACCINATION IN EMPLOYEES OF THE JOINT STOCK COMPANY "RUSSIAN RAILWAYS" (JSCO "RZD") ON INVESTMENT FOR THE EMPLOYER
by: D. A. Zhukov
Published: (2016-02-01)

Cost-Effectiveness Analysis of the Use of V116, a 21-Valent Pneumococcal Conjugate Vaccine, in Vaccine-Naïve Adults Aged ≥ 65 Years in the United States
by: Zinan Yi, et al.
Published: (2024-11-01)

PHARMACOECONOMIC ASSESSMENT OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN IMMUNIZATION OF CHILDREN IN RUSSIAN FEDERATION
by: A. V. Rudakova, et al.
Published: (2014-01-01)

Vaccination against Pneumococcal Infections of High-Risk People: Pharmacoeconomic Aspects
by: A. V. Rudakova, et al.
Published: (2020-01-01)

Cost-effectiveness analyses of 20-valent pneumococcal conjugate vaccine in children and adults: A narrative review
by: Aiko Shono, et al.
Published: (2025-12-01)

Economic Evaluation of Transitioning to the 20-Valent Pneumococcal Conjugate Vaccine in the Dutch Paediatric National Immunisation Programme
by: Esra Çakar, et al.
Published: (2025-02-01)

Cost-effectiveness of vaccination against pneumococcal infection of adults at risk within the federal and regional programs
by: A. V. Rudakova, et al.
Published: (2019-12-01)

Economic evaluation of childhood pneumococcal conjugate vaccination programs in Qinghai and Hainan provinces, China
by: Haonan Zhang, et al.
Published: (2025-12-01)

Impact of invasive and noninvasive pneumococcal diseases on adult populations: risk factors and vaccination status
by: Hasip Kahraman, et al.
Published: (2025-02-01)

Time-Driven Activity-Based Costing (TDABC) applied in a chemotherapy department of a public reference oncology hospital
by: Amanda Oliveira Serra-Campos, et al.
Published: (2025-08-01)

Burden of invasive pneumococcal disease, non-invasive all-cause pneumonia, and acute otitis media in hospitalized US children: a retrospective multi-center study from 2015 to 2020
by: Salini Mohanty, et al.
Published: (2024-12-01)

A Decade of Experience in the use of 13-Valent Conjugated Polysaccharide Pneumococcal Vaccine in Russian Federation
by: N. I. Briko, et al.
Published: (2023-09-01)

Global distribution and characteristics of pneumococcal serotypes in adults
by: Haruka Maeda, et al.
Published: (2025-12-01)

Evaluating Free PPV23 Vaccination for the Elderly in Nanning, China: A Cost-Effectiveness Analysis
by: Zhengqin Su, et al.
Published: (2025-07-01)

Parliamentary amendments aimed at the Brazilian Unified National Health System and the reelection of municipal mayors in Brazil in 2024
by: João Gabriel Ribeiro Pessanha Leal, et al.
Published: (2025-05-01)

The cost of dementia in Brazil
by: Fabiana Araújo Figueiredo da Mata, et al.
Published: (2025-04-01)

SUS (Unified Health System) after 25 years: is there anything to celebrate?
by: José Eduardo de Siqueira
Published: (2013-01-01)

Vaccinal Prevention of Pneumococcal Infection in Children
by: A. A. Baranov, et al.
Published: (2015-12-01)

Health care resource use and costs associated with adult pneumococcal disease in the United States from 2017 to 2019, stratified by age and health risk: a retrospective cohort study
by: Nicole Cossrow, et al.
Published: (2025-07-01)

Strategies for pneumococcal vaccination in older adults in the coming era
by: Kei Nakashima, et al.
Published: (2024-12-01)

EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE: EMERGING DATA FROM INVASIVE PNEUMOCOCCAL DISEASE, PNEUMONIA, ACUTE OTITIS MEDIA AND NASOPHARYNGEAL CARRIAGE
by: Ralf Rene Reinert, et al.
Published: (2012-06-01)

Pneumococcal Vaccine Uptake in Adults Before and After Hospitalization for Pneumococcal Infections in Hong Kong, 2015 to 2024
by: King-Pui Florence Chan, et al.
Published: (2025-05-01)

Brazil’s benign breast disease care profile and geospatial analysis
by: Dayan Sansone, et al.
Published: (2025-04-01)

Epidemiology of Streptococcus pneumoniae serotypes in children before and after pneumococcal vaccination
by: I. N. Protasova, et al.
Published: (2021-12-01)

What do Patients Know About Pneumococcal Vaccine?
by: Fatma Çiftci, et al.
Published: (2017-08-01)

Vaccine Prevention of Pneumococcal Infection in Children
by: Alexander A. Baranov, et al.
Published: (2018-07-01)

Pneumococcal sternoclavicular septic arthritis: A rare manifestation of invasive pneumococcal disease
by: Yongdeok Shin, et al.
Published: (2025-01-01)

The New Era of Pneumococcal Vaccination in Adults: What Is Next?
by: Lale Ozisik
Published: (2025-05-01)

Public health system expenditure on motor vehicle collisions in Brazil: an ecological study
by: Sofia Wagemaker Viana, et al.
Published: (2025-03-01)

ANALYSIS OF PNEUMOCOCCAL VACCINATION EFFICACY AND SAFETY IN CHILDREN WITH VARIOUS DISABILITIES OF HEALTH
by: A. G. Gaivoronskaya, et al.
Published: (2012-04-01)

Psychiatric hospitalizations in the Unified Health System: an observational study on hospitalization rates from 2012 to 2023
by: Karen Murakami Yano, et al.
Published: (2025-04-01)

Morbidity and hospitalization costs of chronic diseases for the Unified National Health System
by: Pedro Henrique Teixeira Soto, et al.
Published: (2015-08-01)

Morbidity and hospitalization costs of chronic diseases for the Unified National Health System
by: Pedro Henrique Teixeira Soto, et al.
Published: (2015-08-01)

Vaccinal Prevention of Lower Respiratory Tract Pneumococcal Disease in Adults Without Immunosuppression
by: I. A. Guchev
Published: (2020-05-01)

A Cross-Sectional Survey to Identify Current Pneumococcal Vaccination Practices and Barriers in Rural Community Pharmacies
by: Ashley H. Chinchilla, et al.
Published: (2025-07-01)